Matthew Dellatorre
Stock Analyst at Goldman Sachs
(4.50)
# 1,045
Out of 4,649 analysts
23
Total ratings
93.3%
Success rate
55.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Dellatorre
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Rated: Buy | $19 → $21 | $18.15 | +15.70% | 9 | Jul 31, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintained: Buy | $45 → $50 | $36.77 | +35.98% | 10 | Apr 30, 2026 | |
| VTRS Viatris | Reiterated: Hold | $10 → $12 | $16.23 | -26.06% | 4 | Oct 22, 2025 |
Amneal Pharmaceuticals
Jul 31, 2026
Rated: Buy
Price Target: $19 → $21
Current: $18.15
Upside: +15.70%
Teva Pharmaceutical Industries
Apr 30, 2026
Maintained: Buy
Price Target: $45 → $50
Current: $36.77
Upside: +35.98%
Viatris
Oct 22, 2025
Reiterated: Hold
Price Target: $10 → $12
Current: $16.23
Upside: -26.06%